The Curious Case of Aspartame: How the Same Evidence Can Yield Seemingly Different Conclusions
Update Magazine | Spring 2024
Tech Support: FDA’s Evolving Regulatory Plan for Drug- and Device-Enabling Software
Update Magazine | Winter 2023
Risk Sharing Agreements in Brazil
Update Magazine | Winter 2023
Implementing MoCRA: FDA Releases New Draft Guidances on Insanitary Conditions for Tattoo Ink and Cosmetic Product Registration & Listing
Update Magazine | Winter 2023
Food Labeling Regulation An Overview from Brazil and Latin America
Update Magazine | Winter 2023
The Accelerated Approval Program: Desiderata for a Proper Solution to the Untimely Completion of Confirmatory Trials
Update Magazine | Winter 2023
Regulatory Innovation: Where You Stand Depends on Where You Sit
Update Magazine | Winter 2023
The Grocer Will Fill Your Order Now: Modernizing Online Food Shopping Becomes a Priority for Federal Agencies
Update Magazine | Fall 2023
FDA’s Adoption of NSF/ANSI 455-3 National GMP Cosmetic Standard Under MoCRA Could Model World Class Example of Public–Private Partnership in a Once-a-Century Opportunity GalleryFDA’s Adoption of NSF/ANSI 455-3 National GMP Cosmetic Standard Under MoCRA Could Model World Class Example of Public–Private Partnership in a Once-a-Century Opportunity
FDA’s Adoption of NSF/ANSI 455-3 National GMP Cosmetic Standard Under MoCRA Could Model World Class Example of Public–Private Partnership in a Once-a-Century Opportunity
Update Magazine | Fall 2023
Lacks v. Thermo Fisher Scientific Inc.—An Extraordinary Event from More than 70 Years Ago That Led to a Lawsuit, Resulting in a Settlement
Update Magazine | Fall 2023
